About OBSOLETE: Limbic encephalitis with caspr2 antibodies
OBSOLETE: Limbic encephalitis with caspr2 antibodies is a rare disease catalogued by Orphanet (ORPHA:276402). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to OBSOLETE: Limbic encephalitis with caspr2 antibodies trials.
Search ClinicalTrials.gov for "OBSOLETE: Limbic encephalitis with caspr2 antibodies" or Orphanet code ORPHA:276402 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting OBSOLETE: Limbic encephalitis with caspr2 antibodies trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for OBSOLETE: Limbic encephalitis with caspr2 antibodies. Updated daily.